Results

Total Results: 3,706 records

Showing results for "design sample size".

2721. Success Stories from the AHRQ-Funded Health IT Portfolio (2009) (pdf file)
      digital.ahrq.gov/sites/default/files/docs/page/HITSuccessStories112910.pdf
      May 02, 2014 - Human factors in organizational design and management—IX. … Human factors in organizational design and management—IX. … on what constitutes true user-centered design in this aspect of health IT. … • Include usability/information design in the certification process. … • Include EHR design and functionality in standards and guidelines.

2722. Folic Acid for the Prevention of Neural Tube Defects: Recommendation Statement (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/B8omJCgNDKfJLVXCz6nFw-
      May 01, 2009 - Evidence is insufficient because of: the limited number or size of studies important flaws in study design

2723. A Systems Engineering Approach: Improving Medication Safety with Clinician Use of Health IT - Final Report (pdf file)
      digital.ahrq.gov/sites/default/files/docs/citation/r18hs017020-singh-final-report-2010.pdf
      January 01, 2010 - diagnosis on prescriptions, patient reminders regarding follow-up, patient-carried medication lists, re-design

2724. Archived: Final Evidence Review: Genital Herpes: Screening | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review55/genital-herpes-screening-2005
      March 15, 2005 - However, data from reported cases do not represent a sufficient sample size for reaching reliable and … Study/Year N Population Antiviral/Dose Design … Study/Year N Population Antiviral/Dose Design

2725. EvidenceNow Key Drivers and Change Strategies (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/tools-and-materials/key_drivers_descriptions.pdf
      February 01, 2019 - EvidenceNow Key Drivers and Change Strategies EvidenceNow Key Drivers and Change Strategies Tools & Resources Change Strategy: Develop a process to search for new evidence and other changes related to Key Driver 1 Change Strategy: Develop an inter-professional QI team and other changes related to Key Driver…

2726. EvidenceNow Key Drivers and Change Strategies | Agency for Healthcare Research and Quality
      www.ahrq.gov/evidencenow/tools/keydrivers/description.html
      October 01, 2020 - EvidenceNow Key Drivers and Change Strategies Below are descriptions of each key driver and change strategy in the EvidenceNOW Key Driver Diagram. Key Driver 1: Seek, select, and customize the best evidence for use by the practice The practice of medicine evolves in response to new knowledge about what care…

2727. Archived: Colorectal Cancer: Screening | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening-june-2016
      June 15, 2016 - however, the USPSTF appreciates the challenges inherent in performing such trials, given the large sample … sizes and long time horizons required. … the investigators adjusted for known potential risk factors for colorectal cancer, given the study design … In addition, it is unclear based on the study design whether the benefit accrued from 1 or multiple colonoscopies … The NordICC Study: rationale and design of a randomized trial on colonoscopy screening for colorectal

2728. Treatments for Acute Pain: A Systematic Review (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-protocol-acute-pain-treatments.pdf
      August 08, 2019 - , year, setting, country, sample size, eligibility criteria, population and clinical characteristics … The results of these studies are at least as likely to reflect flaws in the study design as to show … (e.g., quality, geographic setting, clinical setting, study design type, use of crossover design).46 … features (e.g., use of run-in periods or crossover design). … Opioid prescribing limits for acute pain: potential problems with design and implementation.

2729. Evidence-Summary-CER-206-Sodium-And-Potassium-Intake-Effects-On-Chronic-Disease-Outcomes-And-Risk (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-206-evidence-summary-sodium-potassium.pdf
      June 01, 2018 - For both sodium and potassium, evidence is synthesized by study design (odd-numbered vs. even-numbered … We did not assess the evidence regarding the most effective intervention design(s). … However, a number of studies omitted many details of study design and conflict of interest, so actual … organized by a PICOTSS (populations, interventions, comparators, outcomes, timings, settings, study design … Study Design • Observational studies predominated for long term chronic disease outcomes.

2730. Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/thromboembolism-update-disposition.pdf
      June 22, 2017 - size, why not considering combining all the arms? … The different arms may have similar sample sizes. It helps to include all relevant data. … size, may combine data from all the arms. … The node sizes are related to total sample size. This is standard for presenting these maps. … research, and at the same time, make clear where new research is needed, and what types of study design

2731. Disposition of Comments for Evidence Report #208 Part 5 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/public-reporting-quality-improvement_disposition-comments.pdf
      July 26, 2012 - review treatment effect is interpreted as the impact of public reporting regardless of the study design … Peer Reviewer 6 Methods In the quality review criteria, why did you not consider sample size? … observation and more detail is provided in Appendix F and additional wording has been added to clarify that sample … size can be a consideration as part of the assessment of whether the comparisons are appropriate.

2732. Evidence Summary: Colorectal Cancer: Screening | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary19/colorectal-cancer-screening
      May 18, 2021 - Studies whose design was subject to a high risk of bias were excluded, including those studies subject … Data Synthesis and Analysis The results were synthesized by KQ, type of screening test, and study design … a registry follow-up for screen-negative persons were included, only results from the former study design … Empirical evidence of design-related bias in studies of diagnostic tests. … Design: Study did not use an included design.

2733. 4. Assessment of the Intervention | Agency for Healthcare Research and Quality
      www.ahrq.gov/research/findings/final-reports/crcscreeningrpt/crcscreen4.html
      April 01, 2018 - Health Care Systems for Tracking Colorectal Cancer Screening Tests 4. Assessment of the Intervention Previous Page Next Page Table of Contents Health Care Systems for Tracking Colorectal Cancer Screening Tests Executive Summary 1. Introduction 2. Description of the Intervention 2. Descriptio…

2734. Final Evidence Summary: Unhealthy Drug Use: Screening | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/drug-use-illicit-screening
      June 09, 2020 - Both methadone trials used an unblinded design—one trial compared methadone vs usual care and the other … Design of the NIDA clinical trials network validation study of Tobacco, Alcohol, Prescription Medications … Design of NIDA CTN Protocol 0047: screening, motivational assessment, referral, and treatment in emergency … brief intervention in primary care for problem drug use in a randomized controlled trial: rationale, design … Study design: Not a randomized clinical trial or case-crossover trial (KQs 1, 3, 4, 5); not a large cohort

2735. Enhancing self-management of T2DM with an Automated Reminder and Feedback System (pdf file)
      digital.ahrq.gov/sites/default/files/docs/publication/r18hs017276-burns-final-report-2011.pdf
      January 01, 2011 - Methods Study Design This study was designed as a prospective, randomized trial of the ASMM, including … Considerations in design of health IT for home use. … Aim 1 Specific Aim 2 Specific Aim 3 Scope Background Settings and Participants Methods Study Design

2736. Specific Tools To Support Change (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/qitoolkit/pdi/g2_pdi_specifictoolstosupportchange.pdf
      January 01, 2011 - rough.aspx Sharon Martin Community Health Fund Guide A SMART Fund Guide to Using Outcomes to Design

2737. Specific Tools To Support Change (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/qitoolkit/combined/g2_combo_specifictoolstosupportchange.pdf
      January 01, 2011 - rough.aspx Sharon Martin Community Health Fund Guide A SMART Fund Guide to Using Outcomes to Design

2738. Calculating Community-Level Statistics for HCUPnet: Methods (pdf file)
      hcup-us.ahrq.gov/tech_assist/data_query/Methods_Community_Statistics20230207.pdf
      December 01, 2022 - Rates based on a small number of observations may fluctuate more widely than rates based on larger sample … sizes.

2739. 13-MDM347013 30..38 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/outcomes-testing-evaluation_research.pdf
      January 01, 2009 - Although primary outcome measures represent the principal focus of the study and have a pivotal role in sample … size calculations and statistical testing, most trials will also collect data on secondary outcome … Using the principles of randomized controlled trial design to guide test evaluation.

2740. 13-MDM347013 30..38 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/whitepaper4-bossuyt02262010-2.pdf
      January 01, 2009 - Although primary outcome measures represent the principal focus of the study and have a pivotal role in sample … size calculations and statistical testing, most trials will also collect data on secondary outcome … Using the principles of randomized controlled trial design to guide test evaluation.